Hope you’re ready to binge-watch a marathon of milestones because the LSI Alumni are back with 15 new milestones 🍿
This week the #LSIAlumni closed new funding rounds, granted FDA clearance, launched new products, and much more on the road to #LSIEurope24.
Your 60-second news recap:
Access Vascular, Inc. — James Biggins
→ Presented new data demonstrating that its MIMIX® hydrophilic biomaterial significantly reduces bacterial adhesion and thrombus accumulation in their catheters compared with conventional catheters.
AiM Medical Robotics — Gregory Fischer
→ Announced a partnership with Brigham and Women's Hospital for the First Human Clinical Study for MRI-guided Device Placement in the Brain.
→ Additionally announced a collaboration with LSI Alumni, Synaptive Medical to integrate the Modus Nav neuro-navigation software with AiM's robot, which is also demonstrated in this trial.
Brainomix — Michalis Papadakis
→ Announced the FDA clearance of its latest product, Brainomix 360 e-Lung.
CorTec — Dr. Oliver Baertl
→ Granted FDA IDE approval for an Early Feasibility Study using CorTec’s Closed-Loop Brain Interchange implant system.
Deep Blue Medical Advances, Inc. — Bill Perry
→ Received the Luis Villalobos Award from Angel Capital Association as Innovative Life Science Company of 2024.
Egg Medical — Robert Wilson
→ Partnered with Levant to bring its EggNest Radiation Protection System to Israel.
OUI Medical Inc — Dr Adarsh M Patil
→ Granted a utility patent for its P-scope device. The device is a disposable, portable handheld scope that includes an integrated camera, screen, processor, battery, and biopsy forceps.
Oxford Endovascular Ltd. — Mike Karim
→ Raised £8M in a Series A funding round led by Parkwalk Advisors.
Pristine Surgical — Bryan Lord, David Carey
→ Announced the addition of Christopher Cleary to its Board of Directors.
S2N Health — Amy Siegel, Haley Woloshen
→ Closed a Seed funding round led by Excelerate Health Ventures.
→ Expanded its Board of Directors by adding seasoned Medtech entrepreneur and executive Martha Shadan who has more than three decades of experience in the life science industry.
Shoulder Innovations — Rob Ball
→ Launched its latest product, the InSet™ 95 Humeral Stem designed to enhance surgical outcomes and improve patient recovery for those suffering from poor bone quality.
Valcare Medical — Steve Sandweg
→ Announced enrollment of the first two patients in AMEND™ TS European pilot study.
Vessl Prosthetics — Sydney Robinson
→ Announced the appointment of Tres Wright as its Go To Market and Sales Advisor.
Volta Medical — Théophile Mohr Durdez
→ Announced positive results from its FDA IDE trial, Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation.
XEOS
→ Announced that Vincent Keereman, Co-Founder and CMO, has been appointed to CEO.
Congratulations to all the LSI Alumni who made major news this week!